Hypothesis: thalidomide embryopathy-proposed mechanism of action (Q33831075)

29 July 2017

1 reference

title

Hypothesis: thalidomide embryopathy-proposed mechanism of action (English)

1 reference

29 July 2017

0 references

Stephens TD

1 reference

29 July 2017

Fillmore BJ

series ordinal

1 reference

29 July 2017

publication date

1 March 2000

1 reference

Birth Defects Research Part A: Clinical and Molecular Teratology

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

189-195

1 reference

Was tumour necrosis factor-alpha responsible for the fetal malformations associated with thalidomide in the early 1960s?

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Thalidomide: lack of mutagenic activity across phyla and genetic endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

IGF-I: a mitogen also involved in differentiation processes in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Genomic organization of human and mouse genes for vascular endothelial growth factor C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

The integrin αv gene: Identification and characterization of the promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Characterization of the entire transcription unit of the mouse fibroblast growth factor 1 (FGF-1) gene. Tissue-specific expression of the FGF-1.A mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Regulation of Vascular Endothelial Growth Factor Expression by Insulin-Like Growth Factor I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Proposed mechanisms of action in thalidomide embryopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

A developmental model for thalidomide defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Oxidative damage in chemical teratogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Analysis of the human type I insulin-like growth factor receptor promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Effects of the mesonephros and insulin-like growth factor I on chondrogenesis of limb explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

Teratological tests of the hydrolysis products of thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9926%28200003%2961%3A3%3C189%3A%3AAID-TERA6%3E3.0.CO%3B2-W

10.1002/(SICI)1096-9926(200003)61:3<189::AID-TERA6>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

release_ykomjqc3yvdy3p4qvquttuumu4

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ykomjqc3yvdy3p4qvquttuumu4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference